Anthony G Proakis

Title: Anthony G Proakis: Innovator in Coronary Blood Flow Enhancement

Introduction

Anthony G Proakis is a notable inventor based in Richmond, VA (US). He has made significant contributions to the field of medicine, particularly in enhancing coronary blood flow in mammals. His innovative approach has led to the development of a unique method that holds promise for improving cardiovascular health.

Latest Patents

Proakis holds a patent for a method aimed at increasing coronary blood flow in mammals. The patent describes compounds of a specific general formula that are useful for this purpose. The formula includes various components where R can be hydrogen, acetyl, p-fluorobenzoylpropyl, carbamoyl, N-methylcarbamoyl, N,N-dimethylcarbamoyl, phenylcarbamoyl, or N-(.omega.-morpholinoethyl)carbamoyl. Additionally, R1 is hydrogen, while R2 can be hydrogen or hydroxy. The patent also discusses the potential for R1 and R2 to form a second bond between the carbon atoms bearing these groups. Furthermore, R3 can be hydrogen or fluorine, along with pharmaceutically acceptable acid addition salts.

Career Highlights

Anthony G Proakis is associated with A. H. Robins Company, Incorporated, where he has been able to apply his expertise in the development of innovative medical solutions. His work has been instrumental in advancing the understanding of coronary blood flow and its implications for mammalian health.

Collaborations

Proakis has collaborated with Bernard V Franko, contributing to the advancement of their shared goals in medical innovation. Their partnership has fostered a productive environment for research and development.

Conclusion

Anthony G Proakis is a distinguished inventor whose work in enhancing coronary blood flow has the potential to impact cardiovascular health significantly. His contributions through patents and collaborations highlight his commitment to innovation in the medical field.